Author

S. Sheela

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

A. D. Sung· 1 shared C. B. DeStefano· 1 shared C. Lai· 1 shared C. S. Hourigan· 1 shared D. Rizzieri· 1 shared D.-Y. Kim· 1 shared G. W. Roloff· 1 shared H. Y. Wong· 1 shared

Activity by Year

2018-2018 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. D. Sung

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Molecular measurable residual disease testing of blood during AML cytotoxic therapy for early prediction of clinical response

H. Y. Wong, A. D. Sung, K. E. Lindblad, S. Sheela, G. W. Roloff, D. Rizzieri, M. Goswami, M. P. Mule, N. R. Ramos, J. Tang, J. Thompson, C. B. DeStefano, K. Romero, L. W. Dillon, D.-Y. Kim, , C. S. Hourigan

This study evaluates molecular residual disease in AML patients during chemotherapy, finding stable variant allele frequencies that may indicate limited therapeutic response.

bioRxiv · Sep 20, 2018Cancer Biology